Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells

David A. Ingram, Mary Jo Wenning, Kevin Shannon, D. Wade Clapp

Research output: Contribution to journalArticle

14 Scopus citations


The development of molecularly targeted treatments of adult leukemias warrants investigation of these targets in similar pediatric leukemias. The NF1 tumor suppressor gene, which encodes a GTPase activating protein for p21ras, is frequently inactivated in juvenile myelomonocytic leukemia (JMML). Other patients with JMML acquire activating RAS gene mutations. Recipient mice reconstituted with Nf1-/- fetal hematopoietic cells develop a myeloproliferative disease (MPD) that models the human disease. JMML arises from clonal expansion of a hematopoietic stem cell, and JMML cells and murine Nf1-/- hematopoietic cells are hypersensitive to granulocyte macrophage-colony stimulating factor and KitL, the ligand for c-kit. We generated embryos doubly mutant for the Wv allele of c-kit and Nf1 to ask if reduction of c-kit activity would delay or prevent the development of MPD. Despite a reduction in c-kit activity to approximately 10% of wild-type levels, Nf1-/-; Wv/Wv cells induced MPD in recipient mice.

Original languageEnglish (US)
Pages (from-to)1984-1986
Number of pages3
Issue number5
StatePublished - Mar 1 2003

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Leukemic potential of doubly mutant Nf1 and W<sup>v</sup> hematopoietic cells'. Together they form a unique fingerprint.

Cite this